Curaleaf QMID gains Australian approval and expands to New Zealand
AI Summary- Curaleaf International and Jupiter Research secured Australian and New Zealand market access for QMID.
- 15 September 2026 marked QMID's Australian TGA registration as a Class IIb medical device.
- QMID was certified under EU Medical Device Regulation as a Class IIa device in May 2025.